In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice
- PMID: 8103211
In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice
Abstract
Fibroblast cultures were derived from mouse embryos containing either one (p53+/-) or two (p53-/-) inactivated p53 alleles and compared to normal embryo fibroblasts for a number of growth parameters. Early passage p53-deficient embryo fibroblasts (p53-/-) divided faster than normal embryo fibroblasts, achieved higher confluent densities, and had a higher fraction of division-competent cells under conditions of low cell density. Flow cytometry studies of early passage embryo fibroblasts showed that the percent of p53-deficient cells in G0/G1 was lower than in normal cells, consistent with the argument that p53 mediates a G1 block. When p53-deficient and normal cells were passaged for long periods of time, the homozygote (p53-/-) fibroblasts grew at a high rate for over 50 passages and never entered a non-growing senescent phase characteristic of the heterozygote (p53+/-) and normal (p53+/+) cells. The p53-deficient fibroblasts were genetically unstable during passaging, with the p53-/- cells showing a high degree of aneuploidy and the p53+/- cells displaying a moderate level of chromosomal abnormalities by passage 25. Surprisingly, the heterozygote cells lost their single wild type allele very early during culturing and in spite of this loss most heterozygote lines entered into senescence. We conclude that the loss of p53 by itself is insufficient to confer immortality on a cell, but does confer a growth advantage. Taken together, the findings confirm that the absence of p53 promotes genomic instability, which in turn may result in genetic alterations which directly produce immortality.
Similar articles
-
Vanadate induces G2/M phase arrest in p53-deficient mouse embryo fibroblasts.J Environ Pathol Toxicol Oncol. 2002;21(3):223-31. J Environ Pathol Toxicol Oncol. 2002. PMID: 12435075
-
Enhanced proliferative potential in culture of cells from p53-deficient mice.Oncogene. 1993 Dec;8(12):3313-22. Oncogene. 1993. PMID: 7504233
-
Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence.Oncogene. 1999 Sep 30;18(40):5525-34. doi: 10.1038/sj.onc.1202938. Oncogene. 1999. PMID: 10523829
-
Prevention of mammalian DNA reduplication, following the release from the mitotic spindle checkpoint, requires p53 protein, but not p53-mediated transcriptional activity.Oncogene. 1998 Nov 26;17(21):2743-51. doi: 10.1038/sj.onc.1202210. Oncogene. 1998. PMID: 9840938
-
Gamma-ray-induced cell killing and chromosome abnormalities in the bone marrow of p53-deficient mice.Radiat Res. 1996 Sep;146(3):259-66. Radiat Res. 1996. PMID: 8752303
Cited by
-
Generation and characterization of two immortalized dermal fibroblast cell lines from the spiny mouse (Acomys).PLoS One. 2023 Jul 7;18(7):e0280169. doi: 10.1371/journal.pone.0280169. eCollection 2023. PLoS One. 2023. PMID: 37418364 Free PMC article.
-
Lentiviral in situ targeting of stem cells in unperturbed intestinal epithelium.BMC Biol. 2023 Jan 11;21(1):6. doi: 10.1186/s12915-022-01466-1. BMC Biol. 2023. PMID: 36627630 Free PMC article.
-
Empirical single-cell tracking and cell-fate simulation reveal dual roles of p53 in tumor suppression.Elife. 2022 Sep 20;11:e72498. doi: 10.7554/eLife.72498. Elife. 2022. PMID: 36125118 Free PMC article.
-
Cell Death and the p53 Enigma During Mammalian Embryonic Development.Stem Cells. 2022 Mar 31;40(3):227-238. doi: 10.1093/stmcls/sxac003. Stem Cells. 2022. PMID: 35304609 Free PMC article. Review.
-
Developmental Acquisition of p53 Functions.Genes (Basel). 2021 Oct 23;12(11):1675. doi: 10.3390/genes12111675. Genes (Basel). 2021. PMID: 34828285 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous